Latest updates for Kyowa Hakko
Fresh curated links around Kyowa Hakko are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- 塩野義製薬、米国のバイオ医薬品企業を買収へ 3155億円で
- Kirin's purchase of Blackmores yields results 3 years later: president
- Mitsui to help speed cancer drug research in Asia with patient database
Post angles to try
Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
asia.nikkei.com
/3 weeks ago
Kirin's purchase of Blackmores yields results 3 years later: president
asia.nikkei.com
/1 month ago
Mitsui to help speed cancer drug research in Asia with patient database
asia.nikkei.com
/1 month ago
Roche-owned Chugai Pharma to ramp up in-house output with 50% capex boost
qchron.com
/1 month ago
KANEKA UBIQUINOLâ„¢ WINS NUTRAINGREDIENTS ASIA INGREDIENT OF THE YEAR: HEALTHSPAN AWARD 2026
Award Shines Spotlight on Ubiquinol's Role in Mitochondrial Health and Mitoceutical Innovation in the Global Healthspan Movement
qchron.com
/1 month ago
Akeso 2026 Interim Results: Strong Commercialization Momentum; IO2.0+ Global Strategy Redefining Clinical Standards; Bis...
HONG KONG, Aug. 27, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced its 2026 interim results. During the reporting period, the Company achieved reco...
pharmexec.com
/2 weeks ago
<![CDATA[MFN Raises the Stakes for Japan Launch Pricing]]>
qchron.com
/1 day ago
ImmunoForge to Showcase Proprietary Platform Technologies and Next-Generation Oncology & Phase 2 Clinical Pipelines...
SEOUL, South Korea and COLOGNE, Germany, Oct. 22, 2026 /PRNewswire/ -- ImmunoForge Co., Ltd., a clinical-stage biopharmaceutical company dedicated to developing transformative ther...
seekingalpha.com
/2 weeks ago
Daiichi Sankyo Company, Limited (DSNKY) Q1 2026 Earnings Call Transcript
webwire.com
/1 month ago
Astellas Becomes Host City Partner for One Young World 2027 Tokyo Summit
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) today announced that it has become the first Host City Partner for the One Young World 2027 Tokyo Su...
pharmexec.com
/2 weeks ago
<![CDATA[Naoki Okamura: Post-Patent Plan and Purpose]]>
pharmexec.com
/1 month ago
<
blog.priceplow.com
/1 month ago
PLT Health Solutions Heads to Vitafoods Asia 2026 as a First-Time Exhibitor, Debuting Next-Gen Kinexa in Asia
PLT Health Solutions is exhibiting at Vitafoods Asia for the first time, setting up at Booth H6-K58 this September 2-4 in Bangkok, Thailand with a portfolio of more than 30 clinica...
cafepharma.com
/2 weeks ago
Kiniksa
Kiniksa Anonymous (not verified) Mon, 10/05/2026 - 04:07 field_thread_url https://cafepharma.com/boards/threads/kiniksa.658756/ board na...
japantimes.co.jp
/3 weeks ago
From geisha face paint to servers, Sakai Chemical emerges as AI linchpin
Production capacity is quickly filling up at the Osaka-based company, which provides raw materials for capacitors necessary in AI data centers.
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.
Sources covering Kyowa Hakko
rss.asahi.com
Recent coverage from public sources
Public source
rssfeeds.webwire.com
Recent coverage from public sources
Public source
cafepharma.com
Recent coverage from public sources
Public source
asia.nikkei.com
Recent coverage from public sources
Public source
blog.priceplow.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source